Click Therapeutics
Click Therapeutics develops and commercializes software as prescription medical treatments for various diseases. Their platform combines neuroscience with software to create digital therapeutics that are prescribed by physicians. They have FDA-cleared products and are advancing treatments in psychiatry, neurology, and other areas.
What is Click Therapeutics?
Click Therapeutics is a company that creates software-based medical treatments. They develop, validate, and commercialize prescription digital therapeutics for unmet medical needs. Their approach uses AI and neuroscience to deliver personalized treatments via mobile apps. **Use cases**: Treat major depressive disorder, Prevent episodic migraine, Manage negative symptoms of schizophrenia, Adjunct to antidepressant medication, Enhance drug therapies, Improve patient outcomes **Key features**: Prescribe digital treatments via app; Combine software with pharmacotherapy; AI-driven personalized therapy; FDA-cleared products available; Neuromodulatory interventions; Mobile-based therapeutic exercises; Data-driven insights for patients; Integration with standard care **Who it's for**: People with chronic conditions such as depression, migraine, or schizophrenia who need adjunctive treatments. Also, pharmaceutical companies looking to enhance drug therapies with software. **Credibility**: research with Otsuka, Boehringer Ingelheim; founder David Benshoof Klein; press: Deloitte Technology Fast 500, PharmaVoice 100, Builtin Best Places to Work
Click Therapeutics is a company that creates software-based medical treatments. They develop, validate, and commercialize prescription digital therapeutics for unmet medical needs. Their approach uses AI and neuroscience to deliver personalized treatments via mobile apps.
Key features
- digital therapeutics
- prescription app
- AI-enabled
- software-enhanced drugs
- neuromodulation
- clinical validation
- mobile treatment
- Prescribe digital treatments via app
- Combine software with pharmacotherapy
- AI-driven personalized therapy
- FDA-cleared products available
- Neuromodulatory interventions
- Mobile-based therapeutic exercises
- Data-driven insights for patients
- Integration with standard care
Use cases
- Treat major depressive disorder
- Prevent episodic migraine
- Manage negative symptoms of schizophrenia
- Adjunct to antidepressant medication
- Enhance drug therapies
- Improve patient outcomes
Who is it for
- People with chronic conditions such as depression
- migraine
- or schizophrenia who need adjunctive treatments. Also
- pharmaceutical companies looking to enhance drug therapies with software.